Trial Of “Choroquine” On Coronavirus Patients Turns Into More Complications As Heart Fails

Nigerian father threatens to take daughter away

The deadly disease of Covid-19 Coronavirus pandemic which has an alarming world wide case of about 2,206,676 and about 148,663 deaths and 558,440 recovered persons. It is still the world most dreaded disease. In Nigeria alone , it has about 442 cases and about and about 152 recovered cases and 13 deaths.

While early studies suggested that an anti-malarial drug could be used to combat COVID-19, a new trial indicates that the drug could actually do more harm than good contrary to it’s early report which indicated it as one of  the vital drug that is essential to the fighting of Coronavirus.

A trial of the drug, called chloroquine, has been halted after some patients developed ‘dangerous’ heart complications. During the trial, which took place at the Tropical Medicine Foundation in Brazil, 440 coronavirus patients were given chloroquine. Participants were either given a high dose of the drug or a low dose, although the study was double blind, meaning that neither the patients or their doctors knew which dose they were receiving or that could be administered that could help in curing the patients.

Worryingly, several patients in the high dose group experiences heart rhythm problems, while two patients developed a fast, abnormal heart rate before dying. Based on these results, the trial has now been halted.

In the study, published in medRxiv, the researchers, led by Mayla Gabriela Silva Borba, wrote: “Our study raises enough red flags to stop the use of such [high] dosage … worldwide in order to avoid more unnecessary deaths.”

While chloroquine appears to have some nasty side effects, other drugs are showing promising results for treating coronavirus.

You may also like

Leave a Reply